HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Soo Lim Selected Research
Soo Lim Research Topics
Disease
75
Type 2 Diabetes Mellitus (MODY)
05/2024 - 01/2008
54
Insulin Resistance
04/2024 - 02/2007
23
Atherosclerosis
02/2024 - 01/2008
19
Obesity
04/2024 - 01/2006
19
Body Weight (Weight, Body)
02/2024 - 01/2006
18
Cardiovascular Diseases (Cardiovascular Disease)
08/2022 - 06/2008
17
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 03/2010
13
Hypertension (High Blood Pressure)
11/2023 - 03/2009
13
Diabetes Mellitus
01/2023 - 06/2008
12
Inflammation (Inflammations)
01/2022 - 10/2009
11
Dyslipidemias (Dyslipidemia)
05/2024 - 01/2013
11
Coronary Artery Disease (Coronary Atherosclerosis)
02/2024 - 11/2011
11
Hypoglycemia (Reactive Hypoglycemia)
01/2024 - 02/2011
10
Glucose Intolerance
11/2021 - 02/2007
9
Coronary Stenosis (Coronary Artery Stenosis)
08/2022 - 07/2009
8
Weight Loss (Weight Reduction)
01/2024 - 01/2011
7
Weight Gain
02/2024 - 01/2013
7
Heart Failure
01/2024 - 01/2021
6
Stroke (Strokes)
02/2024 - 03/2009
5
Non-alcoholic Fatty Liver Disease
02/2024 - 12/2015
5
Fatty Liver
02/2024 - 01/2014
5
Albuminuria
01/2024 - 04/2014
5
Abdominal Obesity
11/2021 - 01/2013
5
Atherosclerotic Plaque (Atheroma)
01/2021 - 10/2009
5
Gestational Diabetes (Gestational Diabetes Mellitus)
10/2019 - 11/2005
5
Prediabetic State (Prediabetes)
10/2017 - 10/2013
5
Pathologic Constriction (Stenosis)
01/2017 - 07/2009
4
Hypothyroidism
01/2020 - 06/2009
4
Thyroid Neoplasms (Thyroid Cancer)
01/2016 - 07/2010
4
Hypertriglyceridemia
10/2014 - 01/2011
4
Hypercholesterolemia
12/2013 - 01/2011
3
Overweight
01/2023 - 11/2017
3
COVID-19
01/2022 - 06/2020
3
Thyrotoxicosis
07/2018 - 02/2018
3
Diabetic Retinopathy (Retinopathy, Diabetic)
01/2014 - 01/2013
2
Disease Progression
04/2024 - 02/2018
2
Myocardial Infarction
02/2024 - 12/2019
Drug/Important Bio-Agent (IBA)
72
Glucose (Dextrose)
FDA Link
Generic
05/2024 - 02/2007
27
Insulin (Novolin)
FDA Link
04/2024 - 06/2008
25
Metformin (Glucophage)
FDA Link
Generic
05/2024 - 08/2012
20
Lipids
IBA
04/2024 - 01/2009
18
Adiponectin
IBA
02/2024 - 01/2008
13
Triglycerides (Triacylglycerol)
IBA
02/2024 - 08/2008
13
Calcium
IBA
08/2022 - 07/2009
12
Biomarkers (Surrogate Marker)
IBA
03/2023 - 07/2010
11
Sitagliptin Phosphate (Januvia)
FDA Link
01/2024 - 08/2012
11
Cholesterol
IBA
06/2019 - 07/2010
10
Sodium-Glucose Transporter 2 Inhibitors
IBA
04/2024 - 01/2017
9
HDL Cholesterol
IBA
02/2024 - 02/2012
9
C-Reactive Protein
IBA
01/2023 - 01/2006
9
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
06/2020 - 09/2013
8
Sodium
IBA
04/2024 - 12/2014
8
Sodium-Glucose Transport Proteins
IBA
04/2024 - 01/2018
7
Blood Glucose (Blood Sugar)
IBA
04/2024 - 06/2014
7
lobeglitazone
IBA
12/2023 - 11/2015
7
LDL Cholesterol
IBA
01/2023 - 03/2009
7
Glucagon-Like Peptide 1 (GLP 1)
IBA
01/2022 - 02/2011
6
Hypoglycemic Agents (Hypoglycemics)
IBA
04/2024 - 05/2019
6
dapagliflozin
IBA
02/2024 - 01/2018
6
empagliflozin
IBA
01/2024 - 01/2017
5
Cilostazol (Pletal)
FDA Link
Generic
02/2024 - 12/2014
5
Vitamin D
FDA Link
Generic
01/2022 - 01/2012
5
Thyrotropin (Thyroid-Stimulating Hormone)
FDA Link
01/2016 - 06/2008
5
Adipokines
IBA
01/2013 - 01/2011
4
Enzymes
IBA
02/2024 - 11/2011
4
Thiazolidinediones
IBA
02/2024 - 12/2014
4
Dipeptidyl-Peptidase IV Inhibitors
IBA
02/2024 - 12/2015
4
Insulin Glargine (Lantus)
FDA Link
01/2024 - 11/2013
4
2,4-thiazolidinedione (thiazolidinedione)
IBA
12/2023 - 10/2017
4
Glycated Hemoglobin (Glycosylated Hemoglobin)
IBA
01/2023 - 10/2014
4
LC15-0444
IBA
01/2023 - 01/2017
4
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
08/2022 - 01/2017
4
fibroblast growth factor 21
IBA
01/2021 - 11/2010
4
Interleukin-6 (Interleukin 6)
IBA
06/2020 - 11/2010
4
Thyroid Hormones
IBA
01/2020 - 09/2013
4
Rosuvastatin Calcium (Crestor)
FDA Link
03/2019 - 11/2017
4
Mitochondrial DNA (mtDNA)
IBA
01/2014 - 03/2010
3
oxidized low density lipoprotein
IBA
05/2024 - 06/2013
3
Pioglitazone (Actos)
FDA Link
04/2024 - 01/2020
3
Glucagon-Like Peptide-1 Receptor Agonists
IBA
01/2024 - 01/2022
3
semaglutide
IBA
01/2024 - 01/2021
3
(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triol
IBA
01/2024 - 01/2020
3
Amlodipine (Norvasc)
FDA Link
Generic
11/2023 - 05/2017
3
glimepiride (Amarel)
FDA Link
Generic
01/2023 - 01/2017
3
Leptin
IBA
01/2023 - 01/2011
3
Liraglutide
FDA Link
09/2022 - 01/2021
3
25-hydroxyvitamin D
IBA
01/2022 - 03/2013
3
Cytokines
IBA
06/2020 - 04/2010
3
Thyroxine (Levothyroxine)
FDA Link
Generic
01/2020 - 06/2009
3
Creatinine
IBA
05/2017 - 06/2009
3
Apolipoproteins E (ApoE)
IBA
01/2017 - 01/2013
3
Antioxidants
IBA
01/2017 - 01/2011
3
Lipoproteins (Lipoprotein)
IBA
12/2016 - 02/2012
3
C-Peptide
IBA
12/2015 - 04/2011
3
PPAR gamma
IBA
11/2015 - 04/2006
3
HDL Lipoproteins
IBA
06/2014 - 01/2013
3
Vitamin A (Retinol)
FDA Link
Generic
08/2008 - 06/2008
Therapy/Procedure
45
Therapeutics
05/2024 - 06/2009
7
Glycemic Control
07/2023 - 02/2011
3
Aftercare (After-Treatment)
09/2020 - 05/2017